Navigation Links
Vangent and Human Arc Win Business With 13 Medicare Part D Plans
Date:10/24/2007

High-touch, high-tech service helps Medicare beneficiaries avoid loss of

low income subsidy to pay for prescription medications

ARLINGTON, Va., Oct. 24 /PRNewswire/ -- Vangent, Inc., a leading provider of healthcare technology services, and Human Arc (Cleveland, OH), a leading expert in governmental healthcare programs and member eligibility, today announced 13 prominent Medicare Part D plan sponsors retained their services to redeem members who recently received letters from the Centers for Medicare & Medicaid Services (CMS) stating that they will lose their low income subsidies (LIS) for 2008 unless they re-apply for the benefit.

In its September 6, 2007 memo, CMS indicated that it expects plan sponsors to reach out to their members who are losing their LIS deemed status and provide assistance to members with completing the LIS application. The LIS is a government assistance program available to Medicare beneficiaries with income below specified limits. This year, approximately 500,000 Medicare beneficiaries did not automatically retain the benefit and must reapply.

Vangent's comprehensive informis(TM) member interaction management solution will provide contact management to complement Human Arc's proven Part D Solutions(SM) LIS outreach, member screening and enrollment assistance expertise. Together, Vangent and Human Arc will:

-- Contact and qualify undeemed members in an expeditious manner

-- Ensure the LIS application is completed correctly and submitted in its

entirety

-- Electronically submit the application directly to the Social Security

Administration for processing

The informis(TM) approach provides the basis for a continuing member management and retention program which will ensure that Plans protect their "membership" investment and enhance the member experience.

"Not only does this service help those beneficiaries in need, it is also an important service for loyalty and retention," said Mac Curtis, President and CEO, Vangent, Inc. "By reaching out to assist their un-deemed members, health plans are demonstrating how much they value their members and are providing an outstanding customer experience -- a leading differentiator in a competitive market."

"Human Arc's expertise is in understanding these special populations, informing them in a caring and respectful way, and then helping them preserve their healthcare benefits," said Jeffrey L. Markle, Human Arc President and Chief Operating Officer. "The outcome is a better informed, better protected plan member."

About Vangent, Inc.

With over 5,500 employees worldwide, Vangent, Inc. is a leading global provider of consulting, systems integration, human capital management and business process outsourcing services to the U.S. federal and international governments, higher education institutions and corporations. Clients include the Centers for Medicare and Medicaid Services and the U.S. Departments of Defense, Education, Health and Human Services, Justice and Labor, in addition to the Equal Employment Opportunity Commission, the U.S. Office of Personnel Management, and many Fortune 500 companies.

Vangent's Health Solutions practice has more than 20 years' experience managing award-winning customer interaction management contact centers for federal agencies, the commercial healthcare market, as well as state and local governments, both domestic and international. It has a proven track record of successfully designing, building, implementing and operating customer service centers, web-based self-services, and underlying information technologies such as data warehousing in a variety of federal and commercial healthcare settings.

Vangent was named a "Major North American Outsourcing Provider" by Gartner, Inc. in its 2007 CRM Vendor Guide, reaffirming Vangent's prominence as a leading provider of customer service and support on behalf of government and commercial clients.

For more information, visit http://www.vangent.com. For more information about Vangent's comprehensive member interaction management solutions, informis(TM), visit http://www.informis.com.

About Human Arc

Established in 1984, Human Arc employs hundreds of professionals across many states to deliver innovative revenue enhancement solutions to health plans, including specialized PremiumAssist(SM) Dual Eligibility and Part D Solutions(SM) Services to Medicare Advantage, prescription drug and special needs health plans, as well as Best Benefits(SM) Supplemental Security Income enrollment assistance to qualified Medicaid managed plan members.

The firm also serves hospitals, medical centers and other healthcare providers with its Eligibility Enrollment Service(SM), Disproportionate Share Services(SM), Receivables Management Services(SM), Denial Management Solutions(SM) and Claims Management Service(SM).

One of its area's fastest growing privately held companies, Human Arc helps clients optimize their fiscal health in the marketplace while improving healthcare access.

Human Arc has helped hundreds of thousands of people over the last 23 years. The company has set for itself the goal to make a difference in the lives of over a million people per year by 2010.

For more information on Human Arc, visit http://www.humanarc.com.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are those that do not relate solely to historical fact. They include, but are not limited to, any statement that may predict, forecast, indicate or imply future results, performance, achievements or events. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "projects," "likely," "will," "would," "could" and similar expressions or phrases identify forward-looking statements. All forward-looking statements involve risks and uncertainties. The occurrence of the events described, and the achievement of the expected results, depend on many events, some or all of which are not predictable or within our control. In light of these risks and uncertainties, expected results or other anticipated events or circumstances discussed in this press release might not occur. We undertake no obligation, and specifically decline any obligation, to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Vangent, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Controversial deal on public access of the human genome map
4. Man against HIV – new vaccine ready for human trials
5. Scientists plan human cloning clinic in the United States
6. FDA approves Phase 0 trial which tests experimental drugs on humans
7. Human gene number increases
8. First human clone is near
9. Water regulation in humans
10. Fossil teeth and human development
11. Scientists found ancient Human Germ Killer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , ... February 27, 2017 , ... The threat of ... to work for a company involved in the underground testing of nuclear weapons. Years ... for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical ...
(Date:2/27/2017)... ... 2017 , ... Orange County dentist, Dr. A. Rassouli, comments on ... when the bacteria in plaque infect the gums and other tissues supporting the teeth. ... planing or SRP, and can include surgical therapies if the condition has led to ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate smart media ... system brings songs, movies, TV shows and much more apps for user exploration. Its ... An immersive view of 1280 x 720 provides crisp images with remarkable clarity and ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
Breaking Medicine Technology: